Rights and Issues Investment Trust PLC (RIII)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ISIN: | GB0007392078 |
Category Code: | NAV |
TIDM: | RIII |
LEI Code: | 2138002AWAM93Z6BP574 |
Sequence No.: | 215704 |
EQS News ID: | 1534875 |
| |
End of Announcement | EQS News Service |
Plans for an electric battery gigafactory in the UK have been revived after an Australian business struck a deal to buy collapsed Britishvolt.
Stocks could see a correction in 2023 but are generally on the uptrend, thanks to these bullish market indicators, Ned Davis Research said.
I'm not concerned about the short-term economic outlook. I reckon this UK share could be a brilliant addition for my ISA in February. The post 6% dividend yield! A UK share to buy in February and hold for 10 years appeared first on The Motley Fool UK.
Toby Wilson was returning from a night out in York when he stopped off for a rather expensive burger
Investors dumped more Adani stock on Monday as India's opposition staged protests calling for a full inquiry into allegations of major accounting fraud at the country's biggest conglomerate.The main opposition Congress party, which has called for a "serious investigation" into Adani's companies by the central bank and regulator, on Monday staged protests, including in New Delhi and Mumbai.
A host of FTSE 100 dividend stocks have rocketed in recent months. Luckily, there are still plenty of high-yielding bargains out there. The post Have I just missed a once-in-a-lifetime chance to get rich from dividend stocks? appeared first on The Motley Fool UK.
"The intensifying geopolitical contest between Washington and Beijing will inevitably be felt in a bipolar global reserve currency regime as well."
The property market crash is well under way.
The bailout by the Federal Home Loan Bank has critics questioning whether the government-backed enterprise has lost its way.
Mortgage rates have fallen despite the Bank of England raising the Bank Rate last week, as experts said a "fierce price war" had broken out between lenders.
The FTSE index soared above 7,900 points for the first time on Friday. Here are two brilliant blue-chips I'm considering buying for my portfolio. The post 2 FTSE shares I’d buy as the index hits record highs! appeared first on The Motley Fool UK.
The bosses of Britain's leading commercial banks - Barclays, NatWest, HSBC and Lloyds Banking Group - appear before the Treasury select committee of MPs on Tuesday. Potentially the stickiest questions they face, though, will be on the question of whether they are passing on to savers the increases in interest rates made over the past 14 months by the Bank of England - taking Bank Rate, its policy rate, from the record low of 0.1% to 4% as of last Thursday.
Britain's master investor Jim Mellon thinks that global agriculture is going to be disrupted. This former penny stock is a great way to play the trend. The post 1 ex-penny stock that could become a ‘money fountain’ appeared first on The Motley Fool UK.
Goldman brings a voice of reason to the 2023 rally.
The stock market can be a great source of passive income. Our writer picks out two FTSE 250 (INDEXFTSE:MCX) stocks he'd buy for their dividends. The post 2 FTSE 250 stocks I’d buy for massive passive income appeared first on The Motley Fool UK.
THE company that ran the Beales department store chain until it went into administration in 2020 is to be dissolved with creditors millions of pounds out of pocket.
Investing in funds could be an effective way to boost my second income. Here are three investments I'd buy now and look to hold for the long haul. The post 3 investment funds I’d buy right now for a second income appeared first on The Motley Fool UK.
In a hard landing scenario for the economy, Kostin expects the S&P 500 to fall to 3,150, marking a 24% slide from current levels.
Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments are now up against a steep COVID cliff and investor pressure to spend their windfalls wisely. Western drugmakers including Pfizer Inc, BioNTech SE, Moderna Inc, Gilead Sciences Inc, AstraZeneca Plc and Merck & Co are estimated to have brought in about $100 billion in revenue from COVID vaccines and treatments in 2022. Company and analyst estimates suggest those sales could fall by nearly two-thirds this year due to built up product inventories around the world including in the countries that pay the most.
(Bloomberg) -- Chinese stocks extended losses as tension with the US over a suspected spy balloon triggered fears of economic retaliation by the Biden administration. Most Read from BloombergTwin Quakes Kill 2,000 in Turkey and Syria; Millions Lose PowerTurkey’s South Hit by a Second High-Magnitude EarthquakeUS Moves to Recover Chinese Balloon While Weighing RetaliationChina Moves From Contrite to Confrontational Over US BalloonDell to Cut About 6,650 Jobs, Battered by Plunging PC SalesThe Hang
Yahoo Finance